Insider Transactions in Q1 2023 at Editas Medicine, Inc. (EDIT)
Insider Transaction List (Q1 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 03
2023
|
Bruce Eaton EVP, CBO AND CTO |
SELL
Open market or private sale
|
Direct |
101
-0.13%
|
$808
$8.89 P/Share
|
|
Mar 03
2023
|
Michelle Robertson EVP, CHIEF FINANCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
184
-0.17%
|
$1,472
$8.89 P/Share
|
|
Mar 02
2023
|
Bruce Eaton EVP, CBO AND CTO |
BUY
Grant, award, or other acquisition
|
Direct |
16,700
+17.69%
|
-
|
|
Mar 02
2023
|
Gilmore Neil O'Neill CEO |
BUY
Grant, award, or other acquisition
|
Direct |
50,000
+26.79%
|
-
|
|
Mar 02
2023
|
Baisong Mei EVP, CHIEF MEDICAL OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
18,000
+19.07%
|
-
|
|
Mar 02
2023
|
Michelle Robertson EVP, CHIEF FINANCIAL OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
31,500
+22.62%
|
-
|
|
Feb 13
2023
|
Bruce Eaton EVP, CBO AND CTO |
SELL
Open market or private sale
|
Direct |
3,307
-5.14%
|
$29,763
$9.67 P/Share
|
|
Feb 13
2023
|
Michelle Robertson EVP, CHIEF FINANCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
4,287
-5.32%
|
$38,583
$9.67 P/Share
|
|
Feb 13
2023
|
Mark S Shearman EVP, CHIEF SCIENTIFIC OFFICER |
SELL
Open market or private sale
|
Direct |
2,790
-4.08%
|
$25,110
$9.67 P/Share
|
|
Feb 07
2023
|
Bruce Eaton EVP, CBO AND CTO |
SELL
Open market or private sale
|
Direct |
346
-0.54%
|
$3,806
$11.1 P/Share
|
|
Jan 10
2023
|
Michelle Robertson EVP, CHIEF FINANCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
1,752
-2.13%
|
$14,016
$8.16 P/Share
|